» Articles » PMID: 31122307

Fetal Programming by Androgen Excess in Rats Affects Ovarian Fuel Sensors and Steroidogenesis

Overview
Specialty Biology
Date 2019 May 25
PMID 31122307
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Fetal programming by androgen excess is hypothesized as one of the main factors contributing to the development of polycystic ovary syndrome (PCOS). PCOS is more than a reproductive disorder, as women with PCOS also show metabolic and other endocrine alterations. Since both ovarian and reproductive functions depend on energy balance, the alterations in metabolism may be related to reproductive alterations. The present study aimed to evaluate the effect of androgen excess during prenatal life on ovarian fuel sensors and its consequences on steroidogenesis. To this end, pregnant rats were hyperandrogenized with testosterone and the following parameters were evaluated in their female offspring: follicular development, PPARG levels, adipokines (including leptin, adiponectin, and chemerin as ovarian fuel sensors), serum gonadotropins (LH and FSH), the mRNA of their ovarian receptors, and the expression of steroidogenic mediators. At 60 days of age, the prenatally hyperandrogenized (PH) female offspring displayed both an irregular ovulatory phenotype and an anovulatory phenotype with altered follicular development and the presence of cysts. Both PH groups showed altered levels of both proteins and mRNA of PPARG and a different expression pattern of the adipokines studied. Although serum gonadotropins were not impaired, there were alterations in the mRNA levels of their ovarian receptors. The steroidogenic mediators Star, Cyp11a1, Cyp17a1, and Cyp19a1 were altered differently in each of the PH groups. We concluded that androgen excess during prenatal life leads to developmental programming effects that affect ovarian fuel sensors and steroidogenesis in a phenotype-specific way.

Citing Articles

Metabolic Activity in Human Intermuscular Adipose Tissue Directs the Response of Resident PPARγ Macrophages to Fatty Acids.

Chen X, Schubert S, Muller A, Pishnamaz M, Hildebrand F, Nourbakhsh M Biomedicines. 2025; 13(1).

PMID: 39857594 PMC: 11759838. DOI: 10.3390/biomedicines13010010.


Chemerin and Polycystic Ovary Syndrome: A Comprehensive Review of Its Role as a Biomarker and Therapeutic Target.

Palomba S, Seminara G, Costanzi F, Caserta D, Aversa A Biomedicines. 2025; 12(12.

PMID: 39767764 PMC: 11672894. DOI: 10.3390/biomedicines12122859.


Prenatal Androgen Excess Induces Multigenerational Effects on Female and Male Descendants.

Abruzzese G, Ferreira S, Ferrer M, Silva A, Motta A Clin Med Insights Endocrinol Diabetes. 2023; 16:11795514231196461.

PMID: 37705939 PMC: 10496475. DOI: 10.1177/11795514231196461.


Role of Hormones During Gestation and Early Development: Pathways Involved in Developmental Programming.

Abruzzese G, Campo Verde Arbocco F, Ferrer M, Silva A, Motta A Adv Exp Med Biol. 2023; 1428:31-70.

PMID: 37466768 DOI: 10.1007/978-3-031-32554-0_2.


Circular RNA expression profiling in the fetal side of placenta from maternal polycystic ovary syndrome and circ_0023942 inhibits the proliferation of human ovarian granulosa cell.

Zhao C, Zhou Y, Shen X, Gong M, Lu Y, Fang C Arch Gynecol Obstet. 2020; 301(4):963-971.

PMID: 32193602 DOI: 10.1007/s00404-020-05495-5.